NCT02255370View on ClinicalTrials.gov

Curcumin Associated With Thiopurin in the Prevention of Post-op Recurrence in Crohn Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

November 30, 2017

Study Completion Date

June 30, 2018

Conditions
Crohn's Disease
Interventions
DRUG

Curcumin

subjects will be randomized into two arms; they will be given either placebo or curcumin 3g/d per os plus thiopurines during 6 months in a double-blind manner. Rutggerts endoscopic score at 6 months will be the main judgment criteria

Trial Locations (1)

63003

CHU de Clermont-Ferrand, Clermont-Ferrand

All Listed Sponsors
collaborator

3i nature

OTHER

collaborator

Naturopôle Nutrition santé

UNKNOWN

lead

University Hospital, Clermont-Ferrand

OTHER

NCT02255370 - Curcumin Associated With Thiopurin in the Prevention of Post-op Recurrence in Crohn Disease | Biotech Hunter | Biotech Hunter